Mesa Laboratories Inc /Co/MLAB

NasdaqTechnologyIndustrial Instruments For Measurement, Display, and Control
Price (close)
$137.50
Market cap
$769.4M
P/E
160.3x
Revenue (TTM)
$249.7M
Net income
$4.8M
Dividend yield
0.47%
1-year total return
115.8%
Net margin
1.9%
Revenue growth
3.0%
Debt / equity
0.35x

What Mesa Laboratories Inc /Co/ does.

In this annual report, Mesa Laboratories, Inc., a Colorado corporation, together with its subsidiaries is collectively referred to as “we,” “us,” “our,” the “Company,” or “Mesa.” Mesa was organized in 1982 as a Colorado corporation.

We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. We offer products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. We have manufacturing operations in the United States and Europe, and our products are marketed by our sales personnel in North America, Europe and the Asia Pacific region ("APAC"), and by independent distributors throughout the world.

We are headquartered in Lakewood, Colorado and our common stock is listed for trading on the Nasdaq Global Market (“Nasdaq”) under the symbol MLAB.

Revenue and profit, by fiscal year.

Fiscal year202120222023202420252026
Revenue$133.9M$184.3M$219.1M$216.2M$241.0M$249.1M
Net income$3.3M$1.9M$930,000-$254.2M-$2.0M$6.7M
Free cash flow$35.1M$34.8M$23.4M$41.6M$42.6M$39.6M

More on MLAB.

Figures from Mesa Laboratories Inc /Co/'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.